1. Home
  2. MTG vs TLX Comparison

MTG vs TLX Comparison

Compare MTG & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTG
  • TLX
  • Stock Information
  • Founded
  • MTG 1957
  • TLX 2015
  • Country
  • MTG United States
  • TLX Australia
  • Employees
  • MTG N/A
  • TLX N/A
  • Industry
  • MTG Property-Casualty Insurers
  • TLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MTG Finance
  • TLX Health Care
  • Exchange
  • MTG Nasdaq
  • TLX Nasdaq
  • Market Cap
  • MTG 6.4B
  • TLX 5.7B
  • IPO Year
  • MTG 1991
  • TLX N/A
  • Fundamental
  • Price
  • MTG $27.51
  • TLX $11.54
  • Analyst Decision
  • MTG Hold
  • TLX Strong Buy
  • Analyst Count
  • MTG 6
  • TLX 3
  • Target Price
  • MTG $26.67
  • TLX $22.33
  • AVG Volume (30 Days)
  • MTG 2.2M
  • TLX 90.9K
  • Earning Date
  • MTG 07-30-2025
  • TLX 01-01-0001
  • Dividend Yield
  • MTG 2.18%
  • TLX N/A
  • EPS Growth
  • MTG 12.94
  • TLX 798.14
  • EPS
  • MTG 3.05
  • TLX 0.09
  • Revenue
  • MTG $1,218,572,000.00
  • TLX $484,687,790.00
  • Revenue This Year
  • MTG $2.92
  • TLX N/A
  • Revenue Next Year
  • MTG $3.06
  • TLX N/A
  • P/E Ratio
  • MTG $9.02
  • TLX $124.99
  • Revenue Growth
  • MTG 3.26
  • TLX 55.85
  • 52 Week Low
  • MTG $21.94
  • TLX $10.70
  • 52 Week High
  • MTG $28.67
  • TLX $30.36
  • Technical
  • Relative Strength Index (RSI)
  • MTG 60.54
  • TLX N/A
  • Support Level
  • MTG $26.38
  • TLX N/A
  • Resistance Level
  • MTG $27.20
  • TLX N/A
  • Average True Range (ATR)
  • MTG 0.47
  • TLX 0.00
  • MACD
  • MTG 0.19
  • TLX 0.00
  • Stochastic Oscillator
  • MTG 83.90
  • TLX 0.00

About MTG MGIC Investment Corporation

MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection accounts for close to majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia and New York.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: